News

Latest news from Hildred.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
December 9, 2024

Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement

Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement

Read articleDownload article
October 29, 2024

Hildred Capital Management Named to Inc.’s 2024 List of Founder-Friendly Investors

The list honors investment firms that remain actively involved with the businesses in which they invest and that have earned the trust of the entrepreneurs they support.

Read articleDownload article
September 16, 2024

Ben Samit Appointed Managing Director at Hildred Capital Management

Samit has played key roles in pharma services and supported the growth of several portfolio companies.

Read articleDownload article
September 3, 2024

Crown Aesthetics Announces FDA Clearance of New SkinPen® Precision Elite

The first FDA-Cleared microneedling treatment and category leader in dermatology and aesthetics continues to build its legacy with best-in-class technology

Read articleDownload article
August 12, 2024

Crown Laboratories and Revance Announce Entry Into Merger Agreement

Crown Laboratories to acquire Revance Therapeutics for $924M, creating a leading aesthetics and skincare company with innovative product lines and global reach.

Read articleDownload article
April 30, 2024

Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health

Carlin Consumer Health has acquired joint and muscle care brand, Penetrex, from Wellbeam Consumer Health, under undisclosed terms.

Read articleDownload article
March 28, 2024

Hildred Capital Announces Close of Multi-Asset Continuation Fund with Capital Commitments in Excess of $750 Million

Hildred Capital today announced the closing of a multi-asset continuation fund led by Lexington Partners, one of the world’s largest managers of secondary private equity and co-investment funds, and a leading group of limited partners.

Read articleDownload article
February 26, 2024

Wael Fayad and Stephen Hallenbeck Appointed Partners at Hildred Capital Management

Hildred Capital Management, a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies,

Read articleDownload article
February 12, 2024

binx health Enters into National Distribution Agreement with Cardinal Health to Increase Access to the CLIA-waived, FDA-cleared binx io

binx health partners with Cardinal Health to distribute the binx io®, a rapid, FDA-cleared test for chlamydia and gonorrhea, improving access to care nationwide.

Read articleDownload article
January 16, 2024

Hello Bello Welcomes Consumer Products Veteran Will Righeimer as Chief Executive Officer

Mr. Righeimer will hold dual role as he continues to serve as CEO of Hyland's Naturals

Read articleDownload article
January 9, 2024

SportsMed Physical Therapy Acquires Red Bank Physical Therapy

SportsMed's 39th location expands the physical therapy company's multi-disciplinary services to Monmouth County, NJ

Read articleDownload article
December 19, 2023

Hello Bello Secures Future Growth with Sale to Hildred Capital Management

With new private equity ownership, Hello Bello will continue to deliver “Premium for All”.

Read articleDownload article
November 27, 2023

binx health Expands Nationwide Distribution of the binx io Molecular Point-of-Care Platform

Binx Health partners with Fisher Healthcare to increase access to convenient, routine testing for Chlamydia and Gonorrhea.

Read articleDownload article
October 24, 2023

Carlin Consumer Health Acquires Infirst USA Holdings, LLC

Carlin Consumer Health Acquires Infirst USA Holdings, LLC.

Read articleDownload article
October 18, 2023

DermCare Management, a Hildred Capital Management Portfolio company, Continues Growth with Three New Partnerships

DermCare Management proudly announces three new acquisitions, expanding its presence across the country to a total of 68 practice locations.

Read articleDownload article
October 18, 2023

Hyland's Naturals Enters into the Women's Health Category and Unveils New "Here For It" Brand Campaign

Hyland's Naturals is launching a lineup of premium, multi-benefit supplements specifically designed for women.

Read articleDownload article
October 18, 2023

SportsMed Physical Therapy Acquires Mountainside Wellness

SportsMed Physical Therapy acquired the two clinics comprising Mountainside Wellness.

Read articleDownload article
October 11, 2023

Fortune Magazine Names Hyland's Naturals to 2023 Best Workplaces in Manufacturing & Production List

Fortune magazine has selected Hyland's Naturals for the 2023 Fortune Best Workplaces in Manufacturing & Production™ List.

Read articleDownload article
September 25, 2023

Hyland's Naturals Earns Great Place To Work Certification™ for the Second Year in a Row

Hyland's Naturals has been certified as a Great Place To Work for the second consecutive year, with 84% of employees stating it is a great place to work.

Read articleDownload article
May 2, 2023

Hildred Capital Management Completes Strategic Investment in AleraCare

Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers.

Read articleDownload article
May 1, 2023

AleraCare Rebrands Nationally and Consolidates Ambulatory Infusion, Specialty Pharmacy, Home Infusion and Compounding Pharmacy Service Lines

MedicoRx Specialty Pharmacy, Vasco Infusion and VascoRx Specialty Pharmacy subsidiaries to now operate under AleraCare brand name.

Read articleDownload article
April 21, 2023

Hildred eyes deployment of inaugural fund balance

More than 70% of capital from the New York PE firm's first institutional fund has been deployed and reserved, sources said.

Read articleDownload article
January 30, 2023

DermCare Management, a Hildred Capital Management portfolio company, completes a milestone year with 11 acquisitions in 2022

DermCare Management announces the completion of 3 acquisitions in the fourth quarter of 2022.

Read articleDownload article
October 28, 2022

Hyland's Naturals Earns Great Place to Work Certification™

Will Righeimer, CEO of Hyland's Naturals, Elevates Focus on Empowering Employees and Cultivating Positive Workplace Culture.

Read articleDownload article
October 20, 2022

Carlin Consumer Health names Scott Chapman Chief Executive Officer

Mr. Chapman joins Carlin from Advanced Vision Research (“AVR”), the consumer health division of Akorn Operating Company LLC.

Read articleDownload article
July 21, 2022

Hildred Capital Management Appoints Orle Mulamekic Managing Director and Chief Financial Officer

Hildred Capital Management, LLC today announced that Orle Mulamekic has been appointed Managing Director and Chief Financial Officer.

Read articleDownload article
July 12, 2022

Hildred Capital Management Promotes Kevin Regan to Vice President

Hildred Capital Management, today announced that Kevin Regan has been promoted to Vice President.

Read articleDownload article
June 1, 2022

Hyland's Naturals CEO, Will Righeimer, Leads VMS Launch with New Organic and Vegan Gummy Supplements

Hyland's Naturals, a leading consumer health company, today unveiled its lineup of new premium gummies in the vitamins, minerals, and supplements (VMS) category.

Read articleDownload article
May 24, 2022

Crown Laboratories Expands Aesthetics' Portfolio With Acquisition Of Eclipse Medcorp, Llc Assets

Crown Laboratories has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aesthetics-focused assets.

Read articleDownload article
February 22, 2022

DermCare Management Announces the Acquisition of Multiple Dermatology Clinics

DermCare Management, a quickly-growing and innovative family of brands focused on both medical and cosmetic dermatologic services, announced new partnerships with Stone Oak Dermatology, Irradiance Medical Group, Altman Dermatology, and Icecreamwala Dermatology today.

Read articleDownload article
February 15, 2022

Hildred Capital Management Closes Hildred Equity Partners II Fund at $363 Million

Hildred Capital Management LLC announced that it has closed its first institutional fund, Hildred Equity Partners II (the “Fund”) with total commitments of $362.5 million, exceeding its target.

Read articleDownload article
February 8, 2022

HealthCare.com® Extends Previously Announced $180M Financing with Additional $31.5M Investment from Hildred Capital

HealthCare.com, a leading data-driven insurtech platform, announced today the extension of its recent Series C equity round, which was led by Oaktree Capital Management, L.P. (“Oaktree”) as well as existing investors AXIS Capital, Second Alpha and Link Ventures.

Read articleDownload article
February 1, 2022

Hildred Capital Management, LLC, Bourne Partners Strategic Capital and The Emerson Group Launch Carlin Consumer Health

Hildred Capital Management, LLC (“Hildred”) and Bourne Partners Strategic Capital (“Bourne”), together with The Emerson Group (“Emerson”), launch Carlin Consumer Health (“Carlin”) to establish a preeminent consumer health business and to acquire leading over-the-counter (“OTC”) brands.

Read articleDownload article
November 2, 2021

Kareo and PatientPop Merge to Form Tebra, A Digital Healthcare Technology Company Dedicated to Modernizing Healthcare Practices

Kareo, a leader in cloud-based clinical and financial software, and PatientPop, a leader in practice growth technology, today announced the closing of their merger and the unveiling of the combined company’s new name.

Read articleDownload article
August 26, 2021

Crown Laboratories to Acquire StriVectin®, the #1 Independent Prestige Skincare Company in the U.S.

Crown Laboratories has entered into a definitive agreement under to acquire StriVectin.

Read articleDownload article
May 27, 2021

binx health Raises $104 Million in Series E Financing

Financing led by OrbiMed, and includes Arrowmark Partners, Hildred Capital Management, Alta Life Sciences and Parian Global.

Read articleDownload article
February 16, 2021

Butterfly Network, a Global Leader in Democratizing Medical Imaging, Closes Business Combination and Will Begin Trading on the New York Stock Exchange

Announces unaudited 2020 full-year revenue of at least $45 million, representing growth of at least 63%, each above prior forecast

Read articleDownload article
November 20, 2020

Butterfly Network, a global leader in democratizing medical imaging, to be listed on NYSE through a merger with Longview Acquisition Corp.

Butterfly Network’s mission is to enable universal access to superior medical imaging, making high quality ultrasound affordable, easy-to-use, globally accessible and intelligently connected.

Read articleDownload article
October 10, 2019

Hildred Capital Management and Gemini Investors Announce Recapitalization of DermCare and Skin & Beauty Center

Hildred Capital Management and Gemini Investors have completed a majority recapitalization of DermCare Management and Skin & Beauty Center Management.

Read articleDownload article
May 22, 2019

Crown Laboratories Acquires Xycrobe™ Therapeutics, Inc., an Innovator in Skin Microbiome Technology

Crown Laboratories Invests in cutting-edge technological capabilities in the microbiome space.

Read articleDownload article
May 1, 2019

Crown Laboratories Acquires Keri® From GlaxoSmithKline And Receives An Equity Investment From Greenspring Associates

Crown Laboratories adds a portfolio of significant legacy skin care brands to its portfolio.

Read articleDownload article
November 21, 2018

Canaccord Genuity Growth Corp. and Columbia Care LLC Execute Definitive Transaction Agreement

Pursuant to the terms of the Transaction Agreement, the Business Combination will be structured as a merger between Columbia Care and a newly-formed Delaware subsidiary of CGGC.

Read articleDownload article
September 27, 2018

Crown Laboratories Acquires Bellus Medical

Crown Laboratories, a Hildred Capital Partners portfolio company, establishes aesthetics division with innovative, non-invasive product line.

Read articleDownload article
January 5, 2018

Crown Laboratories, Inc., a Hildred Capital Partners Portfolio Company, Acquires Innovative Self-Tanning Brand Vita Liberata

Hildred Capital Partners portfolio company, Crown Laboratories, adds leading, all-natural product line in sunless tanning to the company’s dermatology portfolio.

Read articleDownload article
October 31, 2017

Family Office Hildred Capital in Talks to Raise Outside Capital

Hildred Capital Partners will assume major stake in leading dermatology and skincare product company.

Read articleDownload article
October 30, 2017

Hildred Capital Partners, LLC to Invest in Crown Laboratories, Inc.

Hildred Capital Partners will assume major stake in leading dermatology and skincare product company.

Read articleDownload article
October 3, 2016

The Rise of Hildred Capital Partners

The Solomons sold their pharma business for $28 billion, made 10 investments through their family office, and are now considering raising third-party capital.

Read articleDownload article
September 6, 2016

Pharmaceutics International, Inc. (Pii) Receives $93 Million In Growth Capital

Hildred Capital Partners with Athyrium Capital and Signet Healthcare takes major stake in leading contract development and manufacturing business.

Read articleDownload article